Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Decreased Immunologic Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT02208791
What this trial is testing

Effects of the Quadruple Immunosuppression on Peripheral Blood Lymphocytes and Development of Anti-HLA Antibodies in Kidney Transplant

Who this might be right for
Kidney Transplantation
University of Sao Paulo General Hospital 45
Early research (Phase 1)Study completedNCT00007163
What this trial is testing

Monoclonal Antibody Treatment of Crohn's Disease

Who this might be right for
Crohn's Disease
National Institute of Allergy and Infectious Diseases (NIAID) 40
Post-approval studies (Phase 4)Study completedNCT00476164
What this trial is testing

Study of Rituximab to Treat Chronic Renal Transplant Rejection

Who this might be right for
Kidney TransplantationGraft RejectionImmunosuppression
King's College London 62
Large-scale testing (Phase 3)Study completedNCT02686619
What this trial is testing

Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Hoffmann-La Roche 237
Not applicableNot Yet RecruitingNCT07698093
What this trial is testing

Monitoring of Septic Shock-induced Immunosuppression

Who this might be right for
Sepsis
Hospices Civils de Lyon 300
Early research (Phase 1)Ended earlyNCT00589316
What this trial is testing

Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+7 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00353860
What this trial is testing

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances

Who this might be right for
ImmunosuppressionLeukemia
National Heart, Lung, and Blood Institute (NHLBI) 70
Testing effectiveness (Phase 2)Ended earlyNCT02452424
What this trial is testing

A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Daiichi Sankyo 78
Not applicableStudy completedNCT04762615
What this trial is testing

Impact of Underlying Renal Disease and Immunosuppressive Regimen on Ovarian Reserve in Renal Patients

Who this might be right for
Anti-Mullerian Hormone DeficiencyImmunosuppressionOvarian Reserve+1 more
Wroclaw Medical University 153
Early research (Phase 1)Study completedNCT04199715
What this trial is testing

Safety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed Patients

Who this might be right for
Hepatitis B
Baylor Research Institute 10
Not applicableUnknownNCT02977897
What this trial is testing

Fecal Calprotectin Levels in Mycophenolate Mofetil Induced Diarrhea and Treatment With Octreotide

Who this might be right for
DiarrheaImmunosuppression
University Health Network, Toronto 10
Not applicableActive Not RecruitingNCT04953715
What this trial is testing

Microbiome and Immunosuppression: The Mission Study

Who this might be right for
Kidney Transplant RejectionKidney Transplant
The University of Texas Medical Branch, Galveston 140
Testing effectiveness (Phase 2)Study completedNCT00021801
What this trial is testing

Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in Patients With Diabetes Mellitus: Steroid-Free Regimen

Who this might be right for
Type 1 Diabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Very early researchNot Yet RecruitingNCT07806136
What this trial is testing

Biomarker-Guided Mycophenolate Mofetil Elimination in Low-Risk Older Adult Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Recipient
Virginia Commonwealth University 20
Testing effectiveness (Phase 2)Study completedNCT01929980
What this trial is testing

Bortezomib to Treat Significant Complication of HSCT

Who this might be right for
Allogeneic Stem Cell TransplantationRefractory Autoimmune Cytopenia(s)
Children's Hospital Medical Center, Cincinnati 4
Post-approval studies (Phase 4)UnknownNCT01875224
What this trial is testing

Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression

Who this might be right for
New Onset Diabetes After TransplantKidney Transplantation
University of Arizona 32
Not applicableStudy completedNCT00003196
What this trial is testing

Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+33 more
Fred Hutchinson Cancer Center 63
Testing effectiveness (Phase 2)Study completedNCT00100178
What this trial is testing

New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 126
Early research (Phase 1)Study completedNCT00353535
What this trial is testing

Total Lymphoid Irradiation (TLI) to Prevent Focal Segmental Glomerulosclerosis (FSGS)Recurrence in the Renal Graft

Who this might be right for
Glomerulosclerosis, Focal
University of Sao Paulo 10
Testing effectiveness (Phase 2)Study completedNCT00307125
What this trial is testing

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

Who this might be right for
Kidney TransplantKidney Transplant RecipientGraft Function/Survival+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 757
Next Page
26